Imipramine binds to Amyloid-beta(1-42) monomers in vitro, as shown by NMR spectroscopy.
Beham, J.; Johnson, N. R.; Vögeli, B.; Henen, M. A.; Vugmeyster, L.
Show abstract
Imipramine is known as an older generation tricyclic antidepressant drug. It has been identified in prior studies that imipramine blocks Apolipoprotein E4 (ApoE4)-induced amyloid-{beta}(A{beta}) aggregation and is associated with an improved AD diagnosis [Johnson et al. Alzheimers Research Therapy, 2022, 14, 88]. Using NMR methods such as 1H-1H NOESY and Saturation Transfer Difference Spectroscopy, we demonstrate the binding of A{beta} monomers to imipramine when the full-length A{beta} (1-42) sequence is considered. The more abundant but less toxic form, A{beta} (1-40) does not show interaction with imipramine.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A peptide-neurotensin conjugate that crosses the blood-brain barrier induces pharmacological hypothermia associated with anticonvulsant, neuroprotective and anti-inflammatory properties following status epilepticus in mice 90%
- Twelve phosphomimetic mutations induce the assembly of recombinant full-length human tau into paired helical filaments 90%
- Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiology 90%
Similar papers in this journal
- Antibodies raised against a structurally defined Aβ oligomer mimic protect human iPSC neurons from Aβ toxicity at sub-stoichiometric concentrations 92%
- Quantitative 3D histochemistry reveals region-specific amyloid-β reduction by the antidiabetic drug netoglitazone 91%
- Queuine, a bacterial derived hypermodified nucleobase, shows protection in in vitro models of neurodegeneration 90%
Similar papers in this journal
- Increased Dynamics of α-Synuclein Fibrils by β-Synuclein Leads to Reduced Seeding and Cytotoxicity 91%
- Imbalance in the response of pre- and post-synaptic components to amyloidopathy 90%
- Lactate treatment improves brain biochemistry and cognitive function in transgenic Alzheimer's and wild-type mice 90%
Similar papers in this journal
- Binding of different substrate molecules at the docking site and the active site of γ-secretase can trigger toxic events in sporadic and familial Alzheimer's disease 91%
- Small-molecule inhibitors of the RNA m6A demethylase FTO potently support the survival of dopamine neurons 90%
- Brain single-cell transcriptional responses to bexarotene-activated RXR in Alzheimer's disease model 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.